J Roth Selected Research

peptide VDIPEN

1/2016

Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Roth Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 02/2000
14	Inflammation (Inflammations) 01/2022 - 03/2001
11	Fever (Fevers) 01/2018 - 01/2000
9	Osteoarthritis 01/2022 - 01/2015
6	Synovitis 12/2018 - 11/2003
6	Parkinson Disease (Parkinson's Disease) 01/2007 - 01/2000
5	Arthritis (Polyarthritis) 10/2009 - 01/2003
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2007 - 03/2000
4	Necrosis 12/2015 - 08/2004
3	Type 2 Diabetes Mellitus (MODY) 05/2017 - 11/2000
3	Dyskinesias (Dyskinesia) 08/2016 - 01/2000
3	Infections 01/2011 - 03/2001
3	Body Weight (Weight, Body) 11/2010 - 03/2000
3	Insulin Resistance 11/2010 - 11/2000
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2008 - 06/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2003 - 02/2000
2	Wounds and Injuries (Trauma) 01/2022 - 09/2001
2	Anorexia 01/2018 - 12/2014
2	Seizures (Absence Seizure) 08/2016 - 03/2013
2	Skin Diseases (Skin Disease) 07/2016 - 07/2006
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2016 - 07/2006
2	Osteophyte 01/2016 - 12/2015
2	Hypertension (High Blood Pressure) 01/2016 - 01/2008
2	Lung Diseases (Lung Disease) 08/2014 - 07/2003
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 10/2008 - 12/2007
2	Farber Lipogranulomatosis 12/2006 - 10/2001
2	Carcinogenesis 09/2001 - 07/2000
2	Neoplasm Metastasis (Metastasis) 08/2001 - 07/2000
1	Knee Injuries (Knee Injury) 01/2022
1	Tertiary Lymphoid Structures 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Growth Disorders 01/2018
1	Lethargy 01/2018
1	Huntington Disease (Huntington's Disease) 01/2018
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2017
1	Hypoglycemia (Reactive Hypoglycemia) 02/2017
1	Cardiomyopathies (Cardiomyopathy) 08/2016
1	Dystonia (Limb Dystonia) 08/2016
1	Mcleod Type Neuroacanthocytosis 08/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2016
1	Movement Disorders (Movement Disorder) 08/2016
1	Skin Manifestations 07/2016

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2000
8	CytokinesIBA 10/2021 - 01/2000
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2003
7	S100A12 ProteinIBA 07/2016 - 06/2003
6	Insulin (Novolin)FDA Link 01/2020 - 11/2000
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2000
5	AlarminsIBA 01/2022 - 08/2014
5	Collagenases (Collagenase)FDA Link 10/2021 - 12/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2008
5	S100 Proteins (S 100 Protein)IBA 07/2016 - 03/2000
5	Biological ProductsIBA 01/2016 - 11/2000
5	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 01/2003
4	EnzymesIBA 01/2022 - 07/2006
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 07/2006
4	Interleukin-1 (Interleukin 1)IBA 01/2017 - 12/2008
4	DNA (Deoxyribonucleic Acid)IBA 06/2001 - 03/2000
3	RNA (Ribonucleic Acid)IBA 01/2017 - 09/2001
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2016 - 12/2007
3	C-Reactive ProteinIBA 01/2016 - 01/2005
3	AntigensIBA 10/2009 - 12/2008
3	LipopolysaccharidesIBA 11/2000 - 01/2000
2	HMGB1 Protein (HMG1)IBA 01/2022 - 10/2013
2	AntibodiesIBA 10/2021 - 01/2011
2	InterleukinsIBA 01/2018 - 12/2015
2	oxidized low density lipoproteinIBA 01/2017 - 05/2016
2	Messenger RNA (mRNA)IBA 07/2016 - 12/2008
2	GlucocorticoidsIBA 01/2016 - 03/2013
2	Proteoglycans (Proteoglycan)IBA 12/2008 - 01/2003
2	N 30IBA 10/2008 - 07/2001
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2003 - 12/2001
2	ParaffinIBA 06/2001 - 08/2000
2	Fluorescent Dyes (Fluorescent Probes)IBA 06/2001 - 08/2000
2	Local AnestheticsIBA 03/2001 - 11/2000
1	Complement System Proteins (Complement)IBA 01/2022
1	Blocking AntibodiesIBA 10/2021
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2020
1	SodiumIBA 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Anticarcinogenic AgentsIBA 01/2020
1	ThiazolidinedionesIBA 01/2020
1	IncretinsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	AntipyreticsIBA 01/2018
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2018
1	ProstaglandinsIBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 04/2017
1	Transaminases (Aminotransferases)IBA 08/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2016
1	Etanercept (Enbrel)FDA Link 07/2016
1	Apolipoproteins E (ApoE)IBA 05/2016
1	CholesterolIBA 05/2016

Therapy/Procedure

10	Therapeutics 01/2020 - 07/2000
6	Injections 01/2017 - 11/2000
2	Deep Brain Stimulation 01/2007 - 11/2001
2	Intraperitoneal Injections 07/2006 - 10/2000